 SOUTH SAN FRANCISCO, Calif., May 13, 2021 GLOBE NEWSWIRE -- Nkarta, Inc. Nasdaq: NKTX, a biopharmaceutical company developing engineered natural killer NK cell therapies to treat cancer, today reported financial results for the first quarter ended March 31, 2021. 